Aim:
Background: The primary cause of liver cirrhosis, hepatocellular cancer, and chronic liver disease all significant global public health issues is the hepatitis C virus HCV. The prevalence of hepatitis C varies by nation and around the world. Aims: The most significant and potentially fatal cause of liver cirrhosis has been identified as hepatitis.

Material and methods:
Materials and methods: The study methodology was developed based on an adaptation of a recently published protocol for reviews of HCV. The main features of this methodology are described below. We conducted a systematic search of PubMed to identify published studies on the prevalence, diagnosis, treatment, and control of HCV in these countries.

Results:
Results: Hepatitis C virus HCV serology varies with different genotypes of the virus. This variation in prevalence can be explained by the different risk factors involved, and infection during childbirth, blood and blood products, dialysis, intravenous and transdermal drug use, occupational, casual and social behavior as risk factors for hepatitis transmission in different settings in these countries.

Conclusions:
Conclusions: Hepatitis B and C virus infection impose significant social, economic and even political burdens on these young and dynamic societies. Therefore, clear intervention strategies and policies are needed to combat the consequences of hepatitis B and C at regional and national levels.